
The immunosuppressive drug mycophenolate mofetil (MMF) has been linked by a researcher to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients, suggests a new report.
http://www.sciencedaily.com/releases/2015/10/151015084624.htm